Kay Huebner
About
In The Last Decade
Kay Huebner
292 papers receiving 18.4k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Molecular Biology 13.9k
- Genetics 6.5k
- Oncology 3.7k
- Cancer Research 3.2k
- Immunology 2.0k
Countries citing papers authored by Kay Huebner
This map shows the geographic impact of Kay Huebner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Huebner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Huebner more than expected).
Fields of papers citing papers by Kay Huebner
This network shows the impact of papers produced by Kay Huebner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Huebner. The network helps show where Kay Huebner may publish in the future.
Co-authorship network of co-authors of Kay Huebner
This figure shows the co-authorship network connecting the top 25 collaborators of Kay Huebner. A scholar is included among the top collaborators of Kay Huebner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Huebner. Kay Huebner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 49 | |
| 2 | 14 | |
| 3 | 74 | |
| 4 | 90 | |
| 5 | 31 | |
| 6 | Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. | 59 |
| 7 | The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers. | 47 |
| 8 | Fhit protein expression in endometrial cancers: no correlation with histological grade. | 2 |
| 9 | FHIT RNA and protein expression in oral squamous cell carcinomas. | 13 |
| 10 | FHIT gene expression in human urinary bladder transitional cell carcinomas. | 10 |
| 11 | Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. | 113 |
| 12 | Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival. | 54 |
| 13 | The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. | 55 |
| 14 | FHITness and cancer. | 29 |
| 15 | Loss of FHIT function in lung cancer and preinvasive bronchial lesions. | 218 |
| 16 | The murine Fhit locus: isolation, characterization, and expression in normal and tumor cells. | 28 |
| 17 | Loss of FHIT expression in gastric carcinoma. | 94 |
| 18 | Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. | 105 |
| 19 | 8 | |
| 20 | T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. | 80 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.